Brief: Samsung Biologics Co Q2 Operating. Profit 586.4 Billion Won, Up 22.9% Y/Y
22/07/2026 23:39
BRIEF-Samsung Biologics Co Q2 Operating. Profit 586.4 Billion Won, Up 22.9% Y/Y Samsung Biologics Co Ltd 207940.KS:
Q2 OPERATING. PROFIT 586.4 BILLION WON, UP 22.9% Y/Y
Source text: [ID:]
Further company coverage: 207940.KS
Recent news on SAMSUNG BIOLOGICS
See all newsSouth Korean shares log 6-month closing low as chipmakers fall on profit-taking
South Korean shares fall on profit taking; BOK in focus
South Korean shares post biggest gain in 6 weeks as chipmakers rebound
South Korean shares fall nearly 3% as AI concerns hit chipmakers
South Korean shares start week lower on AI worries